BASF declares end of Force Majeure on Plastomoll DNA, Palatinol N, Hexamoll DINCH and selected Palamoll grades
Advertisement
BASF SE has fixed the causes for the force majeure for its iso-Nonanol- (INA) based plasticizers produced in Ludwigshafen, Germany, and can hence declare the termination of Force Majeure.
The Force Majeure was originally announced on July 21, 2010, due to a shortage of raw materials to produce the plasticizers Plastomoll® DNA, Palatinol® N, Hexamoll® DINCH and selected Palamoll® grades (652, 654, 656, 858) caused by an unforeseeable technical defect in the INA plant in Ludwigshafen, Germany.
Most read news
Other news from the department manufacturing
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Agilent Technologies and University of Technology, Sydney, Open Joint Nuclear Magnet Resonance Facility
Possible antitumor substances in red wine are formed during ageing in oak barrels
New cooperation with Brenntag GmbH and Colonial Chemical, Inc.
Surface science goes inorganic - Powerful concept offers new approach to understanding surfaces of materials
Aseptic Technologies and Sartorius Sign Distribution Agreement
New look for antiques - Paintings and gilt surfaces can be effectively and gently restored with water-based microemulsions
ThyssenKrupp VDM and Zenergy Power get funding for research into innovative wire
BASF and Bend Research join forces to solve bioavailability challenges